Although the difference was not statistically significant, there was a trend toward an increased frequency of p-Smad3-positive tumor cells in the Anti-PD-1+TR group compared to the Chemo+TR group (p = 0.085) (Figure 6c). Here, SMAD3 is linked to neoplasm.